Research Topic · Peer-Reviewed

Ncov

nCoV, short for novel coronavirus, is the provisional designation given to a newly identified coronavirus before it receives a formal taxonomic name, used most prominently for 2019-nCoV, the virus first detected in late 2019 and subsequently named SARS-CoV-2, the cause of COVID-19. Coronaviruses are enveloped, posit…

Curated from this journal's research 📚 7 peer-reviewed articles cited Cited 9× across the literature 🔖 ISSN 2691-8862 🗓 Reviewed June 2026

Overview

nCoV, short for novel coronavirus, is the provisional designation given to a newly identified coronavirus before it receives a formal taxonomic name, used most prominently for 2019-nCoV, the virus first detected in late 2019 and subsequently named SARS-CoV-2, the cause of COVID-19. Coronaviruses are enveloped, positive-sense single-stranded RNA viruses whose surface spike protein mediates attachment to host-cell receptors and entry; this protein is a principal target of neutralising antibodies and of efforts to map B-cell epitopes for diagnostics and vaccine design. SARS-CoV-2 spreads chiefly through respiratory droplets and aerosols and produces illness ranging from asymptomatic infection and mild respiratory symptoms to severe pneumonia, respiratory failure, and death, with characteristic findings on chest imaging in more serious cases. Research on the novel coronavirus has spanned its origin and transmission, computational prediction of immunogenic epitopes, viral kinetics under different treatment regimens, the role of imaging such as chest computed tomography in diagnosis and assessment, and the rapid development of vaccines, alongside critical evaluation and, where warranted, retraction of unsupported claims. Understanding the virology, immunology, clinical course, diagnosis, and treatment of nCoV infection has been central to managing the pandemic and to preparing for future emerging coronaviruses, informing prevention, therapeutic strategy, and the design of vaccines and diagnostic methods.

Research published in this journal

7 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 7 articles above have been cited 9 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Ncov, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.